289 related articles for article (PubMed ID: 10619859)
1. Targeting of the chemokine receptor CCR1 suppresses development of acute and chronic cardiac allograft rejection.
Gao W; Topham PS; King JA; Smiley ST; Csizmadia V; Lu B; Gerard CJ; Hancock WW
J Clin Invest; 2000 Jan; 105(1):35-44. PubMed ID: 10619859
[TBL] [Abstract][Full Text] [Related]
2. Combined blockade of the chemokine receptors CCR1 and CCR5 attenuates chronic rejection.
Yun JJ; Whiting D; Fischbein MP; Banerji A; Irie Y; Stein D; Fishbein MC; Proudfoot AE; Laks H; Berliner JA; Ardehali A
Circulation; 2004 Feb; 109(7):932-7. PubMed ID: 14757698
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the chemokine receptor CCR1 prolongs corneal allograft survival.
Hamrah P; Yamagami S; Liu Y; Zhang Q; Vora SS; Lu B; Gerard CJ; Dana MR
Invest Ophthalmol Vis Sci; 2007 Mar; 48(3):1228-36. PubMed ID: 17325167
[TBL] [Abstract][Full Text] [Related]
4. Differential role of CCR2 in islet and heart allograft rejection: tissue specificity of chemokine/chemokine receptor function in vivo.
Abdi R; Means TK; Ito T; Smith RN; Najafian N; Jurewicz M; Tchipachvili V; Charo I; Auchincloss H; Sayegh MH; Luster AD
J Immunol; 2004 Jan; 172(2):767-75. PubMed ID: 14707046
[TBL] [Abstract][Full Text] [Related]
5. Prevention of acute murine cardiac allograft rejection: anti-CD4 or anti-vascular cell adhesion molecule one monoclonal antibodies block acute rejection but permit persistent graft-reactive alloimmunity and chronic tissue remodelling.
Orosz CG; Huang EH; Bergese SD; Sedmak DD; Birmingham DJ; Ohye RG; VanBuskirk AM
J Heart Lung Transplant; 1997 Sep; 16(9):889-904. PubMed ID: 9322138
[TBL] [Abstract][Full Text] [Related]
6. Organ-specific differences in the function of MCP-1 and CXCR3 during cardiac and skin allograft rejection.
Haskova Z; Izawa A; Contreras AG; Flynn E; Boulday G; Briscoe DM
Transplantation; 2007 Jun; 83(12):1595-601. PubMed ID: 17589343
[TBL] [Abstract][Full Text] [Related]
7. CCR4-deficient mice show prolonged graft survival in a chronic cardiac transplant rejection model.
Hüser N; Tertilt C; Gerauer K; Maier S; Traeger T; Assfalg V; Reiter R; Heidecke CD; Pfeffer K
Eur J Immunol; 2005 Jan; 35(1):128-38. PubMed ID: 15593118
[TBL] [Abstract][Full Text] [Related]
8. Requirement of the chemokine receptor CXCR3 for acute allograft rejection.
Hancock WW; Lu B; Gao W; Csizmadia V; Faia K; King JA; Smiley ST; Ling M; Gerard NP; Gerard C
J Exp Med; 2000 Nov; 192(10):1515-20. PubMed ID: 11085753
[TBL] [Abstract][Full Text] [Related]
9. Beneficial effects of targeting CCR5 in allograft recipients.
Gao W; Faia KL; Csizmadia V; Smiley ST; Soler D; King JA; Danoff TM; Hancock WW
Transplantation; 2001 Oct; 72(7):1199-205. PubMed ID: 11602842
[TBL] [Abstract][Full Text] [Related]
10. A role for fractalkine and its receptor (CX3CR1) in cardiac allograft rejection.
Robinson LA; Nataraj C; Thomas DW; Howell DN; Griffiths R; Bautch V; Patel DD; Feng L; Coffman TM
J Immunol; 2000 Dec; 165(11):6067-72. PubMed ID: 11086038
[TBL] [Abstract][Full Text] [Related]
11. Role of CXCR3 and CCR5 in allograft rejection.
Schnickel GT; Hsieh GR; Garcia C; Shefizadeh A; Fishbein MC; Ardehali A
Transplant Proc; 2006 Dec; 38(10):3221-4. PubMed ID: 17175228
[TBL] [Abstract][Full Text] [Related]
12. Permanent survival of fully MHC-mismatched islet allografts by targeting a single chemokine receptor pathway.
Wang L; Han R; Lee I; Hancock AS; Xiong G; Gunn MD; Hancock WW
J Immunol; 2005 Nov; 175(10):6311-8. PubMed ID: 16272282
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of polymorphonuclear leukocyte-mediated graft damage synergizes with short-term costimulatory blockade to prevent cardiac allograft rejection.
El-Sawy T; Belperio JA; Strieter RM; Remick DG; Fairchild RL
Circulation; 2005 Jul; 112(3):320-31. PubMed ID: 15998678
[TBL] [Abstract][Full Text] [Related]
14. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival.
Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B
J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748
[TBL] [Abstract][Full Text] [Related]
15. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice.
Cai Y; Tang XD; Zhou PJ
Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744
[TBL] [Abstract][Full Text] [Related]
16. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A.
Li J; Xia J; Zhang K; Xu L
J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-6 receptor signaling disruption prevents cardiac allograft deterioration in mice.
Iida S; Omoto K; Kanemitsu I; Setoguchi K; Ishida H; Tanabe K; Suzuki T; Tashiro Y; Kishimoto H; Abe R
Exp Clin Transplant; 2012 Aug; 10(4):375-85. PubMed ID: 22758208
[TBL] [Abstract][Full Text] [Related]
18. Mobilization of T lymphocytes following cardiac transplantation. Evidence that CD4-positive cells are required for cytotoxic T lymphocyte activation, inflammatory endothelial development, graft infiltration, and acute allograft rejection.
Bishop DK; Shelby J; Eichwald EJ
Transplantation; 1992 Apr; 53(4):849-57. PubMed ID: 1533070
[TBL] [Abstract][Full Text] [Related]
19. A novel small-molecule compound targeting CCR5 and CXCR3 prevents acute and chronic allograft rejection.
Akashi S; Sho M; Kashizuka H; Hamada K; Ikeda N; Kuzumoto Y; Tsurui Y; Nomi T; Mizuno T; Kanehiro H; Hisanaga M; Ko S; Nakajima Y
Transplantation; 2005 Aug; 80(3):378-84. PubMed ID: 16082334
[TBL] [Abstract][Full Text] [Related]
20. Deletion of CD98 heavy chain in T cells results in cardiac allograft acceptance by increasing regulatory T cells.
Liu Z; Hou J; Chen J; Tsumura H; Ito M; Ito Y; Hu X; Li XK
Transplantation; 2012 Jun; 93(11):1116-24. PubMed ID: 22588539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]